Mahlet B. Abera, Ph.D. - Publications
Affiliations: | 2014 | Pharmacology | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Oncology, PharmacologyYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Abera MB, Kazanietz MG. Protein kinase Cα mediates erlotinib resistance in lung cancer cells. Molecular Pharmacology. 87: 832-41. PMID 25724832 DOI: 10.1124/Mol.115.097725 | 0.602 | |||
2014 | Wang H, Gutierrez-Uzquiza A, Garg R, Barrio-Real L, Abera MB, Lopez-Haber C, Rosemblit C, Lu H, Abba M, Kazanietz MG. Transcriptional regulation of oncogenic protein kinase Cϵ (PKCϵ) by STAT1 and Sp1 proteins. The Journal of Biological Chemistry. 289: 19823-38. PMID 24825907 DOI: 10.1074/Jbc.M114.548446 | 0.542 | |||
2014 | Garg R, Benedetti LG, Abera MB, Wang H, Abba M, Kazanietz MG. Protein kinase C and cancer: what we know and what we do not. Oncogene. 33: 5225-37. PMID 24336328 DOI: 10.1038/Onc.2013.524 | 0.544 | |||
2013 | Abera M, Sordella R, Kazanietz M. Abstract 5261: PKC alpha is implicated in epithelial to mesenchymal transition and erlotinib resistance in non-small cell lung carcinoma cells. Cancer Research. 73: 5261-5261. DOI: 10.1158/1538-7445.Am2013-5261 | 0.578 | |||
Show low-probability matches. |